BioSpace News Archive

Meridian Bioscience, Inc. announced today that David Phillips , Chairman of the Board of Directors, will retire from the Board of Directors and not seek re-election when his term ends in January 2022.

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) today announced that it has successfully completed its previously announced acquisition of Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS).

Neovasc Inc. announced that the United Kingdom’s Interventional Procedures Programme at the National Institute for Health and Care Excellence has issued guidance supporting the implantation of the Neovasc Reducer™ in appropriate patients suffering from refractory angina, a painful and debilitating condition that causes chest pain when other treatment options have failed or are not possible.

Health Canada has completed its onsite inspection of the Emergent BioSolutions facility in Baltimore, Maryland . The European Medicines Agency and South African Health Products Regulatory Authority also participated in this inspection remotely.

Shipment of GMP DMT, In Vitro HERG and Genotox Assays Completed, and In Vivo Toxicity Assays Underway.

Amgen (NASDAQ:AMGN) will present at the 2021 Piper Sandler Healthcare Conference at 1:00 p.m. ET on Wednesday, Dec. 1, 2021.

Zynex, Inc. (NASDAQ: ZYXI), today announced the company will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference.

Transcutaneous electrical nerve stimulation is the technology in which the electric current generated by the TENS device is used to stimulate the nerves and minimize pains associated with those nerves.

Fact.MR – A Market Research and Competitive Intelligence Provider: According to the latest Fact.MR analysis, the global pulse oximeters market size is estimated at US$ 1.2 Bn in 2019 and projected to witness at a healthy CAGR of 7% during the forecast period.

Fact.MR – A Market Research and Competitive Intelligence Provider: According to Fact.MR, a market research and competitive intelligence provider, the global oncology molecular diagnostic market was estimated at US$ 1.3 Bn in 2016 and is anticipated to expand at a CAGR of 11% from 2021 to 2031.